Targeting Heme Oxygenase-1 for Neuroprotection and Neuroinflammation in Neurodegenerative Diseases
Journal:
Current Drug Targets
Volume:
11
Page:
1517-1531
Author(s):
Agnieszka Jazwa and Antonio Cuadrado
Heme Oxygenase-1 in Tumor Biology and Therapy
Journal:
Current Drug Targets
Volume:
11
Page:
1551-1570
Author(s):
Halina Was, Jozef Dulak and Alicja Jozkowicz
Fighting Tumor Cell Survival: Advances in the Design and Evaluation of Pim Inhibitors
Journal:
Current Medicinal Chemistry
Volume:
17
Page:
4114-4133
Author(s):
F. Anizon, A. A. Shtil, V. N. Danilenko and P. Moreau
Targeting Ras-RAF-ERK and its Interactive Pathways as a Novel Therapy for Malignant Gliomas
Journal:
Current Cancer Drug Targets
Volume:
10
Page:
840-848
Author(s):
H.-W. Lo
The Crosstalk of RAS with the TGF-β Family During Carcinoma Progression and its Implications for Targeted Cancer Therapy
Journal:
Current Cancer Drug Targets
Volume:
10
Page:
849-857
Author(s):
M. Grusch, M. Petz, T. Metzner, D. Ozturk, D. Schneller and W. Mikulits
EDITORIAL [Hot topic: New Therapeutic Advances and Perspectives in Tumour Angiogenesis (Guest Editor: Eddy Pasquier)]
Journal:
Current Cancer Drug Targets
Volume:
10
Page:
877-878
Author(s):
Eddy Pasquier and Nicolas Andre
Anti-Angiogenic Therapies for Children with Cancer
Journal:
Current Cancer Drug Targets
Volume:
10
Page:
879-889
Author(s):
N. Andre, A. Verschuur, J. Rossler and J. Sterba
Implication of Heat Shock Protein 90 (HSP90) in Tumor Angiogenesis: A Molecular Target for Anti-Angiogenic Therapy?
Journal:
Current Cancer Drug Targets
Volume:
10
Page:
890-897
Author(s):
K. Staufer and O. Stoeltzing
Histone Deacetylases: Anti-Angiogenic Targets in Cancer Therapy
Journal:
Current Cancer Drug Targets
Volume:
10
Page:
898-913
Author(s):
D. Mottet and V. Castronovo
Novel Agents in the Management of Lung Cancer
Journal:
Current Medicinal Chemistry
Volume:
17
Page:
4291-4325
Author(s):
B. Kennedy, F. Gargoum, B. Bystricky, D. R. Curran and T. M. O'Connor